TIMP1 and neoplasm: Blocking Timp1 expression with siRNA increased the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine and reversed their resistance to chemotherapy; the combined action of shTIMP1 therapy and gemcitabine induced apoptosis of tumor cells [101].